A carregar...
LCIG in treatment of non‐motor symptoms in advanced Parkinson’s disease: Review of literature
BACKGROUND: For managing nonmotor symptoms (NMS) in advanced Parkinson's disease (PD), levodopa–carbidopa intestinal gel (LCIG) infusion is of interest as it shows lesser plasma fluctuations of both drugs as compared to oral levodopa–carbidopa (LC). OBJECTIVES: To highlight LCIG effect in NMS a...
Na minha lista:
| Publicado no: | Brain Behav |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7507541/ https://ncbi.nlm.nih.gov/pubmed/32677345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1757 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|